1. Expression of thioredoxin and glutaredoxin in experimental hepatocellular carcinoma—Relevance for prognostic and diagnostic evaluation
   Nabil M. Abdel-Hamid et al, 2018, Pathophysiology CrossRef
2. Discovery and validation of surfaceN-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets
   Robyn A A Oldham et al, 2020, Journal for ImmunoTherapy of Cancer CrossRef
3. Six genes as potential diagnosis and prognosis biomarkers for hepatocellular carcinoma through data mining
   Yaqiong Zhang et al, 2019, Journal of Cellular Physiology CrossRef
4. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
   Monica Mossenta et al, 2022, International Journal of Molecular Sciences CrossRef
5. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
   Mahsa Pourhamzeh et al, 2023, Molecular and Cellular Biochemistry CrossRef
6. Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
   Abdallah Essa et al, 2023, Biologics: Targets and Therapy CrossRef
7. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
   Hsiang-chi Tseng et al, 2020, Nature Communications CrossRef
8. Application of adoptive cell therapy in hepatocellular carcinoma
   Dengqiang Wu et al, 2023, Immunology CrossRef
9. Discovery and Biological Evaluation of CD147 N-Glycan Inhibitors: A New Direction in the Treatment of Tumor Metastasis
   Wenqian Li et al, 2020, Molecules CrossRef
10. Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework
    Qian Feng et al, 2023, European Journal of Medical Research CrossRef
11. Structural insights on druggable hotspots in CD147: A bull's eye view
    Dhivya Kumar et al, 2019, Life Sciences CrossRef
12. The Anticarcinogenic Effect of the Apple Polyphenol Phloretin in an Experimental Rat Model of Hepatocellular Carcinoma
    Wafa S. Alansari et al, 2020, Arabian Journal for Science and Engineering CrossRef
13. An IgM monoclonal antibody against domain 1 of CD147 induces non-canonical RIPK-independent necroptosis in a cell type specific manner in hepatocellular carcinoma cells
    Kumpanat Pomlok et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
14. Dual effects of an anti-CD147 antibody for Esophageal cancer therapy
    Miao Wang et al, 2019, Cancer Biology & Therapy CrossRef